Xiaoyuan (shawn) Chen - Nanotechnology

Author Information

Xiaoyuan Shawn Chen is affiliated with the Laboratory of Molecular Imaging and Nanomedicine at the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, USA. Dr. Chen is a prominent figure in the field of nanotechnology and molecular imaging, contributing significantly to advancements in biomedicine.

Research Contributions

Dr. Xiaoyuan Shawn Chen's research spans a variety of topics within the realm of nanotechnology and molecular imaging. His work includes the development of noninvasive imaging techniques, such as dual-modality photoacoustic-ultrasonic imaging for detecting embryo abnormalities and near-infrared probes for luminescence lifetime imaging. He has also explored innovative therapeutic strategies, including photothermal therapy, cancer immunotherapy, and the use of nano-antioxidants for protecting against hepatic ischemia-reperfusion injury. Dr. Chen's research is highly interdisciplinary, impacting fields such as oncology, medical imaging, and drug delivery systems.

Aliases

Dr. Xiaoyuan Shawn Chen is also known by the following aliases: Xiaoyuan Chen, Xiaoyuan S. Chen, and Xiaoyuan (Shawn) Chen.

Publication and Citation Metrics

Metric	Value
Citation Count	73,154
H-index	143
Paper Count	827

Publications:

Noninvasive Dual-Modality Photoacoustic-Ultrasonic Imaging to Detect Mammalian Embryo Abnormalities after Prenatal Exposure to Methylmercury Chloride (MMC): A Mouse Study

DOI: 10.1289/EHP8907

Year: 2022

A "Self-Checking" pH/Viscosity-Activatable NIR-II Molecule for Real-Time Evaluation of Photothermal Therapy Efficacy.

DOI: 10.1002/anie.202200025

Year: 2022

Near-infrared probes for luminescence lifetime imaging

DOI: 10.7150/ntno.63124

Year: 2022

A "Self‐Checking" pH/Viscosity‐Activatable NIR‐II Molecule for Real‐Time Evaluation of Photothermal Therapy Efficacy

DOI: 10.1002/ange.202200025

Year: 2022

Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics

DOI: 10.7150/thno.68182

Year: 2022

A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma

DOI: 10.7150/thno.68456

Year: 2022

Hybrid‐Membrane‐Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor‐Associated Macrophages Polarization and Hypoxia Relief

DOI: 10.1002/adma.202200389

Year: 2022

Enantiomeric alkynyl-protected Au10 clusters with chirality-dependent radiotherapy enhancing effects

DOI: 10.1016/J.NANTOD.2021.101222

Year: 2021

Photodynamic‐Chemodynamic Cascade Reactions for Efficient Drug Delivery and Enhanced Combination Therapy

DOI: 10.1002/advs.202002927

Year: 2021

Protective Effect of Platinum Nano-antioxidant and Nitric Oxide Against Hepatic Ischemia-Reperfusion Injury

DOI: 10.21203/RS.3.RS-660251/V1

Year: 2021

What is the Future of Protein Engineering in Nanotechnology?

What Technologies Are Used to Enhance Precision and Resolution?

What is the Future of Nanotechnology Based Drug Delivery?

Where Can I Find Nanotechnology Programs?

What are the Challenges Associated with High Speed Scanners?

How Can Nanotechnology Improve Water Quality?

What are Some Commonly Used Instruments in Nanotechnology?

Can Plotly Handle Large Datasets Common in Nanotechnology Research?

What is the Future of Nanotechnology in Thermostats?

What are the Types of Chemical Transducers?

Partnered Content Networks

Relevant Topics